J. Belón

Preliminary results of a phase II study to evaluate gefitinib combined with docetaxel and cisplatin in patients with recurrent and/or metastatic squamous-cell carcinoma of the head and neck

J. Belón, I. Rodríguez, Yolanda Escobar et al. · Journal of Clinical Oncology · 2005 · 43 citations

Medicine, Oncology, Pharmacotherapy +17

Randomized phase II/III clinical trial of induction chemotherapy (ICT) with either cisplatin/5-fluorouracil (PF) or docetaxel/cisplatin/5-fluorouracil (TPF) followed by chemoradiotherapy (CRT) vs. crt alone for patients (pts) with unresectable locally advanced head and neck cancer (LAHNC)

Ricardo Hitt, J.M. Cervera Grau, Antonio López–Pousa et al. · Journal of Clinical Oncology · 2006 · 37 citations

Medicine, Oncology, Radiation Oncology +13

Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group

Jaime Feliú, Manuel González Barón, Carlos García Girón et al. · Cancer · 1996 · 24 citations

Medicine, Oncology, Pharmacology +15

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

Enrique Espinosa, Serafín Morales, Pablo Borrega et al. · Cancer Chemotherapy and Pharmacology · 2004 · 23 citations

Medicine, Oncology, Pharmacology +11

LONG-TERM FUNCTIONAL AND URODYNAMIC RESULTS OF 50 PATIENTS RECEIVING A MODIFIED SIGMOID NEOBLADDER CREATED WITH A SHORT DISTAL SEGMENT

M. Pilar Laguna, M. BRENNINKMEIER, J. Belón et al. · The Journal of Urology · 2005 · 22 citations

Medicine, Surgery, Urology +14